CMS has announced the members of the independent Coronavirus Commission on Safety and Quality in Nursing Homes, as the agency is seeking an independent review and assessment of what happened at nursing homes across the countries when COVID-19 hit.

One of the biggest imaging OEMs is offering healthcare providers using its radiography systems a third party’s AI toolset for detecting lung abnormalities.

The American College of Physicians has released its new Practice Points, which aims to provide rapid clinical advice based on evidence and offer some guidance on wearing masks and respirators.

Harvard researchers have demonstrated a way to cut through tangles of irrelevant information in electronic health records (EHRs) while applying machine learning to spot patterns indicative of specific disease markers.

Hospitals in the U.S. are already using dexamethasone, a commonly known steroid that’s readily available and inexpensive, to treat COVID-19 patients without waiting for confirmation of preliminary results from a British study that found the drug can greatly improve survival.

A federal research arm whose normal work involves developing aerospace warfighting technologies is turning its talents to deploying explainable AI in the war against COVID-19.

The device can also test for malaria and already has CE Mark approval as well as regulatory greenlights in India and Ghana.

A medical student in the U.K. is cautioning proponents of AI in healthcare to beware the technology’s possible adverse effects on medical education.

Between 40% and 45% of COVID-19 infections could be in people who display no symptoms of the illness, according to an analysis by Scripps Research published in Annals of Internal Medicine.

A coalition of 12 surgeon groups has formed a new organization that aims to work with Congress to stop cuts to Medicare payments that could have an adverse effect on patients.